Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Sirolimus in Combination With Oral Cyclophosphamide and Oral Topotecan in Children and Young Adults With Relapsed and Refractory Solid Tumors

NCT01670175 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT01670175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01670175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Sirolimus in Combination With Oral Cyclophosphamide and Oral Topotecan in Children and Young Adults With Relapsed and Refractory Solid Tumors
Lead sponsor
University of California, San Francisco
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2012
Completion date
September 30, 2016
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

childhood solid tumor, malignant solid tumor